This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

 
 

News

  • Metastatic prostate cancer hijacks DNA program for embryonic development

    Metastatic prostate cancer cells that spread throughout the patient's body reactivate a DNA program responsible for fetal prostatic development, new research shows. Cancer researchers led by Wilbert Zwart of the Netherlands Cancer Institute and Oncode Institute, and Matthew Freedman of the Harvard Dana-Farber Cancer Institute in Boston, demonstrated this process in tissue samples taken from hundreds of surgically removed prostate tumors.

    Read More
  • Cancer Core Europe centres develop web-based decision-making support tool for oncologists to improve treatment selection

    In Nature Medicine, clinical researchers from the Cancer Core Europe (CCE) Comprehensive Cancer Cemtres describe a new precision cancer medicine technology to inform the use of individualised treatments in clinical trials, guided by the genomics profile of the tumours.

    Read More
  • More news

Comprehensive Cancer Centre

'The Netherlands Cancer Institute, a center of excellence for the benefit of cancer patients.'

Support Us